KEGG: spo:SPBC25B2.07c
STRING: 4896.SPBC25B2.07c.1
The mug164 protein (encoded by the mug164 gene) in Schizosaccharomyces pombe (fission yeast) is primarily studied for its role in cellular processes. The name "mug" stands for "meiotically upregulated gene," indicating its expression increases during meiosis. This protein (UniProt accession O74779) plays potential roles in reproductive and developmental processes in S. pombe. Understanding mug164 function contributes to our broader knowledge of eukaryotic cell division mechanisms, particularly those conserved between yeast and higher eukaryotes.
Based on product specifications, mug164 antibody has been validated for ELISA and Western blotting applications . These applications allow researchers to detect and quantify mug164 protein expression in various experimental conditions. Western blotting is particularly useful for determining protein molecular weight and relative abundance, while ELISA provides quantitative measurements in solution-phase samples. Researchers should consider performing their own validation studies when applying this antibody to new experimental systems or methods.
| Characteristic | Specification |
|---|---|
| Product Code | CSB-PA525606XA01SXV |
| Host Species | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Target Species | Schizosaccharomyces pombe (strain 972 / ATCC 24843) |
| Immunogen | Recombinant S. pombe mug164 protein |
| Form | Liquid |
| Purification Method | Antigen Affinity Purified |
| Storage Buffer | 50% Glycerol, 0.01M PBS, pH 7.4, 0.03% Proclin 300 |
| Validated Applications | ELISA, WB |
| Storage | -20°C or -80°C, avoid repeated freeze-thaw cycles |
This antibody has been specifically developed for research applications in S. pombe and is not intended for diagnostic or therapeutic use .
While specific protocols may vary based on laboratory conditions and equipment, a general protocol for Western blotting using mug164 antibody includes:
Sample preparation: Lyse S. pombe cells in an appropriate buffer containing protease inhibitors to prevent protein degradation.
Protein quantification: Normalize protein concentrations across samples using Bradford or BCA assay.
SDS-PAGE separation: Load 20-50 μg of protein per lane on an SDS-PAGE gel (typically 10-12%).
Transfer: Transfer proteins to a PVDF or nitrocellulose membrane.
Blocking: Block the membrane with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature.
Primary antibody incubation: Dilute mug164 antibody (initial recommendation 1:1000, but optimization may be required) in blocking buffer and incubate overnight at 4°C.
Washing: Wash membrane 3-4 times with TBST.
Secondary antibody incubation: Incubate with HRP-conjugated anti-rabbit IgG (typically 1:5000) for 1 hour at room temperature.
Detection: Develop using ECL substrate and image appropriately.
Always include appropriate positive and negative controls to validate specificity.
For ELISA applications using mug164 antibody, consider the following optimization steps:
Antibody titration: Perform a checkerboard titration to determine optimal primary antibody concentration (typically starting with dilutions from 1:500 to 1:5000).
Antigen coating concentration: Test various antigen concentrations (0.1-10 μg/ml) to identify the optimal coating concentration.
Blocking optimization: Compare different blocking agents (BSA, non-fat milk, commercial blockers) at various concentrations (1-5%) to minimize background.
Incubation conditions: Optimize temperature (4°C, room temperature, 37°C) and duration (1-24 hours) for each step.
Detection system selection: Choose between colorimetric, fluorescent, or chemiluminescent detection based on required sensitivity.
A standard indirect ELISA protocol would involve coating plates with antigen, blocking, incubating with mug164 antibody, washing, adding enzyme-conjugated secondary antibody, washing again, and developing with appropriate substrate.
Rigorous experimental design requires appropriate controls:
| Control Type | Purpose | Implementation |
|---|---|---|
| Positive Control | Confirm antibody activity | S. pombe wild-type lysate expressing mug164 |
| Negative Control | Validate specificity | mug164 deletion strain lysate |
| Loading Control | Ensure equal protein loading | Probing for housekeeping protein (e.g., actin, tubulin) |
| Primary Antibody Omission | Check secondary antibody specificity | Perform protocol without primary antibody |
| Pre-absorption Control | Validate epitope specificity | Pre-incubate antibody with immunizing peptide |
| Isotype Control | Check for non-specific binding | Non-specific rabbit IgG at same concentration |
Including these controls helps ensure experimental validity and facilitates troubleshooting if unexpected results occur.
As a meiotically upregulated gene product, mug164 protein provides valuable insights into meiotic regulation in S. pombe. Researchers can employ mug164 antibody in several advanced applications:
Time-course expression analysis: Using Western blotting with mug164 antibody to track protein expression during meiotic progression. Samples should be collected at key timepoints (0, 2, 4, 6, 8, 10, and 12 hours) after meiotic induction.
Subcellular localization studies: Combining immunofluorescence with mug164 antibody and fluorescent DNA stains to determine protein localization during different meiotic stages.
Chromatin association analysis: Performing chromatin immunoprecipitation (ChIP) to investigate whether mug164 associates with specific genomic regions during meiosis.
Protein interaction studies: Using mug164 antibody for co-immunoprecipitation to identify interaction partners during different meiotic phases.
Comparative analysis: Examining mug164 expression in various meiotic mutant backgrounds to place it within known regulatory pathways.
These approaches can help elucidate the functional role of mug164 in meiotic processes and reproductive development.
While immunoprecipitation (IP) isn't listed among the validated applications, researchers may adapt the antibody for this purpose with careful optimization:
Antibody amount: Typically, 2-5 μg of antibody per 500 μg of total protein is recommended for IP experiments.
Lysate preparation: Use gentle lysis buffers to preserve protein-protein interactions (e.g., 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% NP-40, protease inhibitors).
Pre-clearing: Pre-clear lysates with Protein A/G beads to reduce non-specific binding.
Antibody incubation: Incubate mug164 antibody with pre-cleared lysate overnight at 4°C with gentle rotation.
Bead selection: Choose Protein A beads for rabbit polyclonal antibodies like mug164 antibody.
Washing stringency: Balance between removing non-specific interactions and maintaining specific ones by adjusting salt concentration in wash buffers.
Elution method: Select between denaturing (SDS sample buffer) or non-denaturing (peptide competition) elution based on downstream applications.
Successful immunoprecipitation can facilitate studies of mug164 protein complexes and post-translational modifications.
Assessing potential cross-reactivity is essential, especially when studying conserved proteins:
Sequence alignment analysis: Compare mug164 sequence with potential homologs in other species to predict cross-reactivity.
Western blot testing: Test the antibody against lysates from multiple species or strains to identify cross-reactivity.
Recombinant protein panel: Use purified recombinant proteins of related family members to evaluate potential cross-reactivity.
Peptide competition: Perform blocking experiments with the immunizing peptide to confirm signal specificity.
Knockout/knockdown validation: Compare signals between wild-type and mug164-depleted samples to confirm specificity.
| Issue | Possible Causes | Solutions |
|---|---|---|
| No signal | Insufficient protein, antibody degradation, failed transfer | Increase protein loading, use fresh antibody, validate transfer with stain |
| High background | Insufficient blocking, antibody concentration too high | Optimize blocking conditions, increase washing, dilute antibody |
| Multiple bands | Non-specific binding, protein degradation, post-translational modifications | Include protease inhibitors, reduce sample heating time, verify with knockout control |
| Weak signal | Low protein expression, insufficient antibody, short exposure | Increase protein concentration, optimize antibody dilution, increase exposure time |
| Inconsistent results | Protein degradation, variable transfer efficiency | Standardize sample preparation, use internal loading control |
Always optimize conditions for your specific experimental system and cell extracts.
Quantitative analysis of Western blot data requires:
Image acquisition: Capture images using a digital system with linear dynamic range (e.g., chemiluminescence imager).
Software selection: Use image analysis software that allows densitometry (ImageJ, Image Lab, etc.).
Background subtraction: Apply consistent background subtraction across all lanes.
Normalization: Normalize mug164 signal to an appropriate loading control (e.g., actin, GAPDH) using the formula:
Technical replicates: Perform at least three independent experiments for statistical analysis.
Statistical analysis: Apply appropriate statistical tests (t-test, ANOVA) to determine significance of observed changes.
Data presentation: Present data as mean ± standard deviation or standard error, clearly indicating sample size and statistical significance.
This approach ensures rigorous quantitative analysis of mug164 expression levels across experimental conditions.
For quantitative ELISA data analysis:
Standard curve generation: Create a standard curve using known concentrations of recombinant mug164 protein.
Curve fitting: Apply appropriate curve fitting (typically 4-parameter logistic regression) to generate the standard curve.
Sample interpolation: Determine unknown sample concentrations by interpolating from the standard curve.
Technical replicates: Run samples in triplicate and report mean values with standard deviation.
Coefficient of variation (CV): Calculate CV to assess assay precision (CV = standard deviation/mean × 100%). Acceptable CV is typically <15% for samples and <10% for standards.
Lower limit of detection (LLOD): Determine LLOD as the mean of blank samples plus 3 standard deviations.
Statistical comparison: Use appropriate statistical tests (t-test for two groups, ANOVA for multiple groups) to compare conditions.
Data visualization: Present data using bar graphs or box plots with clear indication of sample size and statistical significance.
According to product specifications, mug164 antibody should be stored at -20°C or -80°C upon receipt . For long-term storage, -80°C is preferable to maintain antibody activity. The antibody is supplied in a protective buffer containing 50% glycerol, which prevents freezing at -20°C and reduces damage from freeze-thaw cycles.
For working solutions, store at 4°C for up to one month. To maintain antibody quality:
Avoid repeated freeze-thaw cycles by preparing small working aliquots
Thaw frozen antibody slowly on ice rather than at room temperature
Centrifuge briefly after thawing to collect all liquid at the bottom of the tube
Protect from prolonged exposure to light, especially if fluorescently labeled
Never store diluted antibody solutions for extended periods without carriers (BSA)
Antibody performance can deteriorate over time. To validate mug164 antibody activity after storage:
Positive control testing: Run a Western blot with a known positive sample (wild-type S. pombe lysate) alongside a freshly prepared standard.
Titration experiment: Perform a dilution series (e.g., 1:500, 1:1000, 1:2000, 1:5000) to determine if optimal working concentration has changed.
Background assessment: Check for increased background which may indicate antibody degradation.
Sensitivity comparison: Compare signal intensity with previously obtained results using the same samples and protocol.
Functional assay: If used for functional assays like immunoprecipitation, verify that the antibody still pulls down the target protein efficiently.
If significant performance decline is observed, obtaining a new antibody lot is recommended.
Distinguishing genuine signals from artifacts requires several validation approaches:
Knockout/knockdown controls: The gold standard validation uses genetic deletion or knockdown of mug164 to demonstrate signal loss.
Peptide competition assay: Pre-incubating the antibody with excess immunizing peptide should abolish specific binding.
Molecular weight verification: The observed band should match the predicted molecular weight of mug164 (calculated as approximately 50.5 kDa according to product information) .
Signal consistency: Specific signals should be consistent across replicate experiments with minimal variability.
Alternative antibody comparison: When available, compare results with a second antibody targeting a different epitope of mug164.
Multiple detection methods: Confirm findings using complementary techniques (e.g., mass spectrometry) when possible.
This multi-faceted approach helps ensure that observed signals truly represent mug164 protein.
When analyzing changes in mug164 expression during cell cycle:
Temporal resolution: Collect samples at sufficient time points to capture expression dynamics (e.g., every 15-30 minutes during critical phases).
Cell synchronization validation: Verify synchronization efficiency using established cell cycle markers (e.g., Cdc13 for G2/M).
Normalization strategy: Consider whether traditional housekeeping genes maintain constant expression during the cell cycle; use multiple controls if necessary.
Post-translational modifications: Assess whether band shifts might represent modifications rather than expression changes.
Protein half-life considerations: Factor in protein stability when interpreting expression changes (rapid changes may indicate active degradation).
Correlation with transcription: Compare protein expression patterns with mRNA levels when possible to distinguish transcriptional from post-transcriptional regulation.
Subcellular localization changes: Consider whether apparent expression changes might reflect redistribution between subcellular compartments.